Actively Recruiting

Age: 18Years +
All Genders
ID06691204

Comparison of Adductor Pollicis and Abductor Digiti Minimi Muscles as Sites for Neuromuscular Monitoring with Electromyography

Led by Tamas Vegh, MD · Updated on 2024-11-15

46

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating how well the TetraGraph device measures muscle responses at two sites on the arm: the adductor pollicis (thumb) and the abductor digiti minimi (fifth digit). The study focuses on the timing of muscle response during the onset and recovery from neuromuscular blockade caused by rocuronium and reversed by sugammadex. This is important because residual muscle weakness after surgery can cause complications, and monitoring this accurately helps improve patient safety. In this observational study, patients undergoing elective surgeries receive neuromuscular blocking agents including rocuronium followed by reversal with sugammadex. Two TetraGraph devices are placed on different muscles to monitor electrical activity through electromyography (EMG). Measurements are taken frequently from the start of neuromuscular blockade until recovery, including every 20 seconds after sugammadex administration until the patient is extubated. Participants are monitored continuously during surgery with standard equipment and the TetraGraph devices, with recordings taken every 15 seconds during baseline and every 5 minutes during surgery. After surgery, assessments continue until muscle function recovers to a defined level. Researchers measure the rate of recovery from blockade and the incidence of residual muscle weakness one hour after extubation. The study aims to improve understanding of muscle site sensitivity and monitoring techniques in surgical patients.

CONDITIONS

Brief Title

Comparison of Adductor Pollicis and Abductor Digiti Minimi Muscles (Thumb Vs. Fifth Digit) As Sites for Neuromuscular Monitoring with Electromyography

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Willingness to participate and provide informed consent
  • Undergoing elective surgery requiring use of neuromuscular blocking agents such as rocuronium administered during surgery
Not Eligible

You will not qualify if you...

  • History of disorders like stroke, carpal tunnel syndrome, wrist injury with nerve damage, or Dupuytren contracture
  • Presence of systemic neuromuscular diseases such as myasthenia gravis
  • Severe kidney impairment or end-stage liver disease affecting drug processing
  • Surgery involving prepping the arm into the sterile field
  • Receiving rapid sequence induction anesthesia
  • Allergy to rocuronium or sugammadex

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Duration of surgery, typically several hours

Participants undergo neuromuscular monitoring using two devices placed on the hand and fifth digit to measure muscle responses during anesthesia and surgery.

1 intraoperative monitoring session

Long-term Monitoring

Duration - Up to 1 hour after extubation

Participants are monitored after surgery to assess neuromuscular recovery and detect any residual weakness.

Continuous monitoring for up to 1 hour post-extubation

Trial Site Locations

Total: 2 locations

1

University of Debrecen, Department of Anesthesiology and Intensive Care

Debrecen, Hajdú-Bihar, Hungary, 4032

Actively Recruiting

2

University of Debrecen, Debrecen, Hajdú-Bihar 4008

Debrecen, Hungary

Completed

Loading map...

Research Team

G

György NAGY, MD

E

Erzsébet Igbonu-Nagy, BSC

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Comparison of an Acceleromyography- and Electromyography-bas...

Neuromuscular Blockade

Actively Recruiting

2 locations

Comparison of the Train-of-Four Ratio and Modified Train-of-...

Neuromuscular Blockade

Actively Recruiting

1 location

Effect of Deep Neuromuscular Block on the Quality of Recover...

Neuromuscular Blockade

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.

Réka Nemes, Béla Fülesdi, Adrienn Pongrácz...

https://pubmed.ncbi.nlm.nih.gov/28030444

Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision.

T Fuchs-Buder, C Claudius, L T Skovgaard...

https://pubmed.ncbi.nlm.nih.gov/17635389

Use of a train-of-four ratio of 0.95 versus 0.9 for tracheal extubation: an exploratory analysis of POPULAR data.

Manfred Blobner, Jennifer M Hunter, Claude Meistelman...

https://pubmed.ncbi.nlm.nih.gov/31607388

Post-anaesthesia pulmonary complications after use of muscle relaxants (POPULAR): a multicentre, prospective observational study.

Eva Kirmeier, Lars I Eriksson, Heidrun Lewald...

https://pubmed.ncbi.nlm.nih.gov/30224322

Impaired upper airway integrity by residual neuromuscular blockade: increased airway collapsibility and blunted genioglossus muscle activity in response to negative pharyngeal pressure.

Frank Herbstreit, Jürgen Peters, Matthias Eikermann

https://pubmed.ncbi.nlm.nih.gov/19417617

The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium.

E Sundman, H Witt, R Olsson...

https://pubmed.ncbi.nlm.nih.gov/10754616

Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome.

Thomas Ledowski, Samuel Hillyard, Brendan O'Dea...

https://pubmed.ncbi.nlm.nih.gov/23716766